Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 236-237, May 2009

Hypoxia inducible factor (HIF): Its central role in renal cell cancer targeted therapy

Brigham and Women's Hospital, Boston, MA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00222-6

doi:10.1016/j.urolonc.2008.08.006

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 236-237, May 2009

Article Tools

* Image Usage & Resolution